• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸酰胺水解酶的α-酮恶唑抑制剂的优化

Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

作者信息

Kimball F Scott, Romero F Anthony, Ezzili Cyrine, Garfunkle Joie, Rayl Thomas J, Hochstatter Dustin G, Hwang Inkyu, Boger Dale L

机构信息

Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

出版信息

J Med Chem. 2008 Feb 28;51(4):937-47. doi: 10.1021/jm701210y. Epub 2008 Feb 5.

DOI:10.1021/jm701210y
PMID:18247553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2734917/
Abstract

A series of alpha-ketooxazoles containing conformational constraints in the flexible C2 acyl side chain of 2 (OL-135) and representative oxazole C5 substituents were prepared and examined as inhibitors of fatty acid amide hydrolase (FAAH). Exceptionally potent and selective FAAH inhibitors emerged from the series (e.g., 6, Ki = 200 and 260 pM for rat and rhFAAH). With simple and small C5 oxazole substituents, each series bearing a biphenylethyl, phenoxyphenethyl, or (phenoxymethyl)phenethyl C2 side chain was found to follow a well-defined linear relationship between -log Ki and Hammett sigmap of a magnitude (rho = 2.7-3.0) that indicates that the substituent electronic effect dominates, confirming its fundamental importance to the series and further establishing its predictive value. Just as significantly, the nature of the C5 oxazole substituent substantially impacts the selectivity of the inhibitors whereas the effect of the C2 acyl chain was more subtle but still significant even in the small series examined. Combination of these independent features, which display generalized trends across a range of inhibitor series, simultaneously improves FAAH potency and selectivity and can provide exquisitely selective and potent FAAH inhibitors.

摘要

制备了一系列在2(OL-135)的柔性C2酰基侧链中含有构象限制的α-酮恶唑以及代表性的恶唑C5取代基,并将其作为脂肪酸酰胺水解酶(FAAH)的抑制剂进行检测。该系列中出现了极具效力和选择性的FAAH抑制剂(例如,6,对大鼠和重组人FAAH的Ki分别为200和260 pM)。对于带有联苯乙基、苯氧基苯乙基或(苯氧甲基)苯乙基C2侧链的每个系列,当C5恶唑取代基简单且较小时,发现-log Ki与哈米特σ值之间存在明确的线性关系,其大小(ρ = 2.7 - 3.0)表明取代基的电子效应起主导作用,证实了其对该系列的根本重要性,并进一步确立了其预测价值。同样重要的是,C5恶唑取代基的性质对抑制剂的选择性有实质性影响,而C2酰基链的影响更为微妙,但即使在所检测的小系列中仍然显著。这些独立特征在一系列抑制剂系列中呈现出普遍趋势,它们的组合同时提高了FAAH的效力和选择性,并能够提供极具选择性和效力的FAAH抑制剂。

相似文献

1
Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.脂肪酸酰胺水解酶的α-酮恶唑抑制剂的优化
J Med Chem. 2008 Feb 28;51(4):937-47. doi: 10.1021/jm701210y. Epub 2008 Feb 5.
2
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.强效且具选择性的基于α-酮杂环的抑制剂,作用于花生四烯乙醇胺和油酰胺分解代谢酶——脂肪酸酰胺水解酶。
J Med Chem. 2007 Mar 8;50(5):1058-68. doi: 10.1021/jm0611509. Epub 2007 Feb 6.
3
Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.脂肪酸酰胺水解酶的α-酮恶唑抑制剂的构效关系
J Med Chem. 2007 Jul 12;50(14):3359-68. doi: 10.1021/jm061414r. Epub 2007 Jun 9.
4
α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.脂肪酸酰胺水解酶的α-酮杂环抑制剂:酰基侧链构象限制的探索
Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.
5
Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.α-酮杂环酶抑制剂基本取代基效应的探索:脂肪酸酰胺水解酶的强效和选择性抑制剂
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. doi: 10.1016/j.bmcl.2008.06.084. Epub 2008 Jun 28.
6
Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).新型基于酮恶唑的脂肪酸酰胺水解酶(FAAH)抑制剂。
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2109-13. doi: 10.1016/j.bmcl.2008.01.091. Epub 2008 Jan 30.
7
Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.脂肪酸酰胺水解酶的α-酮杂环抑制剂中心杂环的优化
J Med Chem. 2008 Aug 14;51(15):4392-403. doi: 10.1021/jm800136b. Epub 2008 Jul 16.
8
Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.设计、合成并鉴定了同时靶向脂肪酸酰胺水解酶胞质腔 Cys269 位的 α-酮杂环化合物。
J Med Chem. 2014 Feb 13;57(3):1079-89. doi: 10.1021/jm401820q. Epub 2014 Jan 23.
9
Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.含极性头基的 2-酮恶唑型 FAAH 抑制剂的设计、合成与评价。
Bioorg Med Chem. 2012 Jan 15;20(2):1100-12. doi: 10.1016/j.bmc.2011.11.027. Epub 2011 Nov 28.
10
Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.发现一类强效、选择性且有效的可逆性脂肪酸酰胺水解酶α-酮杂环抑制剂,具有镇痛作用。
J Med Chem. 2005 Mar 24;48(6):1849-56. doi: 10.1021/jm049614v.

引用本文的文献

1
N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.N-酰基吡唑:有效的、可调节的丝氨酸水解酶抑制剂。
Bioorg Med Chem. 2019 Apr 15;27(8):1693-1703. doi: 10.1016/j.bmc.2019.03.020. Epub 2019 Mar 11.
2
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.单原子的差异:化学-生物学界面的合成与设计。
J Org Chem. 2017 Dec 1;82(23):11961-11980. doi: 10.1021/acs.joc.7b02088. Epub 2017 Oct 13.
3
Comprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α Inhibitors.

本文引用的文献

1
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.具有显著选择性的新型脂肪酸酰胺水解酶抑制剂的作用机制类别
Biochemistry. 2007 Nov 13;46(45):13019-30. doi: 10.1021/bi701378g. Epub 2007 Oct 19.
2
Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.2-苯并恶唑基-和2-苯并噻唑基-(3-羟基苯基)-甲酮氨基甲酸酯衍生物作为新型脂肪酸酰胺水解酶抑制剂的设计、合成及体外评价
J Med Chem. 2007 Aug 23;50(17):4236-42. doi: 10.1021/jm070501w. Epub 2007 Aug 1.
3
Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
α-酮杂环作为sn-1-二酰基甘油脂肪酶α抑制剂的构效关系综合分析
J Med Chem. 2015 Dec 24;58(24):9742-53. doi: 10.1021/acs.jmedchem.5b01627. Epub 2015 Dec 2.
4
Discovery libraries targeting the major enzyme classes: the serine hydrolases.针对主要酶类的发现型文库:丝氨酸水解酶。
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3807-13. doi: 10.1016/j.bmcl.2014.06.063. Epub 2014 Jun 27.
5
α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.脂肪酸酰胺水解酶的α-酮杂环抑制剂:酰基侧链构象限制的探索
Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.
6
Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.设计、合成并鉴定了同时靶向脂肪酸酰胺水解酶胞质腔 Cys269 位的 α-酮杂环化合物。
J Med Chem. 2014 Feb 13;57(3):1079-89. doi: 10.1021/jm401820q. Epub 2014 Jan 23.
7
Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.通过与两个活性位点残基共价结合来作用的脂肪酸酰胺水解酶抑制剂的合理设计。
J Am Chem Soc. 2013 Apr 24;135(16):6289-99. doi: 10.1021/ja4014997. Epub 2013 Apr 12.
8
Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.脂肪酸酰胺水解酶的磺酰氟抑制剂。
J Med Chem. 2012 Nov 26;55(22):10074-89. doi: 10.1021/jm301205j. Epub 2012 Nov 2.
9
α-Ketoheterocycle-based Inhibitors of Fatty Acid Amide Hydrolase (FAAH).基于α-酮杂环的脂肪酸酰胺水解酶(FAAH)抑制剂
ACS Chem Neurosci. 2012 May 16;3(5):340-348. doi: 10.1021/cn2001206. Epub 2011 Dec 20.
10
Approximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH).通过动态药效基团模型来模拟蛋白质的柔韧性:在脂肪酸酰胺水解酶 (FAAH) 中的应用。
J Chem Inf Model. 2011 Dec 27;51(12):3247-53. doi: 10.1021/ci200371z. Epub 2011 Dec 7.
脂肪酸酰胺水解酶的α-酮恶唑抑制剂的构效关系
J Med Chem. 2007 Jul 12;50(14):3359-68. doi: 10.1021/jm061414r. Epub 2007 Jun 9.
4
Attenuation of allergic contact dermatitis through the endocannabinoid system.通过内源性大麻素系统减轻过敏性接触性皮炎
Science. 2007 Jun 8;316(5830):1494-7. doi: 10.1126/science.1142265.
5
Novel inhibitors of fatty acid amide hydrolase.新型脂肪酸酰胺水解酶抑制剂
Bioorg Med Chem Lett. 2007 Jun 15;17(12):3287-91. doi: 10.1016/j.bmcl.2007.04.009. Epub 2007 Apr 10.
6
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.强效且具选择性的基于α-酮杂环的抑制剂,作用于花生四烯乙醇胺和油酰胺分解代谢酶——脂肪酸酰胺水解酶。
J Med Chem. 2007 Mar 8;50(5):1058-68. doi: 10.1021/jm0611509. Epub 2007 Feb 6.
7
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.脂肪酸酰胺水解酶抑制剂具有广泛的选择性,并会抑制多种羧酸酯酶作为脱靶效应。
Neuropharmacology. 2007 Mar;52(4):1095-105. doi: 10.1016/j.neuropharm.2006.11.009. Epub 2007 Jan 9.
8
Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations.通过量子力学/分子力学模拟阐明脂肪酸酰胺水解酶及其Lys142Ala变体的水解机制。
J Am Chem Soc. 2006 Dec 27;128(51):16904-13. doi: 10.1021/ja065863s.
9
Delineation of a fundamental alpha-ketoheterocycle substituent effect for use in the design of enzyme inhibitors.用于酶抑制剂设计的基本α-酮杂环取代基效应的描述。
J Am Chem Soc. 2006 Nov 1;128(43):14004-5. doi: 10.1021/ja064522b.
10
An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling.一种通过多维分析注释的、调节癌症中醚脂信号通路的酶。
Chem Biol. 2006 Oct;13(10):1041-50. doi: 10.1016/j.chembiol.2006.08.008.